Direxion Daily Healthcare Bull 3X SharesCURE
CURE
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
32% more call options, than puts
Call options by funds: $3.66M | Put options by funds: $2.76M
22% more funds holding
Funds holding: 18 [Q3] → 22 (+4) [Q4]
0.61% more ownership
Funds ownership: 8.39% [Q3] → 9.0% (+0.61%) [Q4]
0% less capital invested
Capital invested by funds: $15M [Q3] → $15M (-$7.58K) [Q4]
100% less funds holding in top 10
Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for CURE.
Financial journalist opinion
Positive
ETF Trends
1 month ago
2 Sectors to Trade as Equity Funds See Higher Inflows
Sometimes traders can set up a potential plays when they see where investor money is flowing. This is available with fund inflows, which saw technology and healthcare equities gain a lion's share of February's flows.

Positive
Zacks Investment Research
1 month ago
5 Leveraged ETFs With Double-Digit Gains Halfway Through Q1
We highlight a bunch of the best-performing leveraged equity ETFs halfway through the first quarter.

Positive
ETF Trends
1 month ago
Rising Number of Flu Cases Could Elevate These ETFs
Cases of the flu have reached elevated levels as of late. This could keep healthcare stocks and ETFs with a healthcare focus on the radar for traders.

Positive
Zacks Investment Research
2 months ago
5 Leveraged ETFs That Witnessed Double-Digit Gains in January
We highlight a bunch of the best-performing leveraged equity ETFs of January.

Positive
Seeking Alpha
3 months ago
CURE: Analyst Estimates Point To Significant Gains In 2025
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks. Since October 2024 the forward P/E ratio for CURE's largest holdings has marginally increased. Even so Wall Street analysts predict a weighted average gain of 21% for CURE's top ten components over the next 12 months.

Neutral
ETF Trends
4 months ago
There Could Be Value in Healthcare Stocks Ahead of 2025
When a new presidential administration is set to take office, there's uncertainty as to whether specific sectors could be impacted. In the case of healthcare, that's certainly the case, especially in biotech.

Positive
Seeking Alpha
6 months ago
CURE: A Leveraged ETF To Own Throughout This Century
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% of the performance of an index heavily concentrated in large-capitalization US healthcare stocks. CURE's top ten holdings trade at a weighted average forward P/E of 28.27, with analysts predicting a 9.78% gain over the next 12 months. The healthcare sector benefits from long-term trends such as an aging population and an increased focus on longevity. Artificial intelligence will also help in developing new treatments.

Positive
Zacks Investment Research
7 months ago
5 Leveraged ETFs With Double-Digit Gains in August
After witnessing steep sell-offs at the start of August, all three major indices end the month with double-digit gains.

Positive
ETF Trends
8 months ago
Q2 Earnings Season Looms Large in Hopes for Broader Stocks Rally
Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.

Neutral
ETF Trends
8 months ago
Can Biotech Heal Itself?
Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.

Charts implemented using Lightweight Charts™